1. Home
  2. HROW vs SCL Comparison

HROW vs SCL Comparison

Compare HROW & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • SCL
  • Stock Information
  • Founded
  • HROW 1998
  • SCL 1932
  • Country
  • HROW United States
  • SCL United States
  • Employees
  • HROW N/A
  • SCL N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • SCL Package Goods/Cosmetics
  • Sector
  • HROW Health Care
  • SCL Consumer Discretionary
  • Exchange
  • HROW Nasdaq
  • SCL Nasdaq
  • Market Cap
  • HROW 1.1B
  • SCL 1.3B
  • IPO Year
  • HROW N/A
  • SCL N/A
  • Fundamental
  • Price
  • HROW $30.66
  • SCL $53.82
  • Analyst Decision
  • HROW Strong Buy
  • SCL
  • Analyst Count
  • HROW 6
  • SCL 0
  • Target Price
  • HROW $59.00
  • SCL N/A
  • AVG Volume (30 Days)
  • HROW 433.0K
  • SCL 102.5K
  • Earning Date
  • HROW 08-06-2025
  • SCL 07-30-2025
  • Dividend Yield
  • HROW N/A
  • SCL 2.85%
  • EPS Growth
  • HROW N/A
  • SCL 47.62
  • EPS
  • HROW N/A
  • SCL 2.45
  • Revenue
  • HROW $212,858,000.00
  • SCL $2,222,111,000.00
  • Revenue This Year
  • HROW $44.92
  • SCL $9.02
  • Revenue Next Year
  • HROW $38.12
  • SCL $6.65
  • P/E Ratio
  • HROW N/A
  • SCL $22.15
  • Revenue Growth
  • HROW 53.49
  • SCL N/A
  • 52 Week Low
  • HROW $19.31
  • SCL $44.23
  • 52 Week High
  • HROW $59.23
  • SCL $94.77
  • Technical
  • Relative Strength Index (RSI)
  • HROW 57.58
  • SCL 46.58
  • Support Level
  • HROW $30.01
  • SCL $53.49
  • Resistance Level
  • HROW $31.63
  • SCL $55.26
  • Average True Range (ATR)
  • HROW 1.59
  • SCL 1.23
  • MACD
  • HROW 0.02
  • SCL -0.25
  • Stochastic Oscillator
  • HROW 66.10
  • SCL 20.56

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

Share on Social Networks: